In addition, Epac activator attenuated, whereas Epac inhibitor exaggerated allergic asthma airway inflammation, both in acute and chronic asthma models, suggesting a protecting role of Epac on asthma airway inflammation. This evidence concerns the gene RAPGEF3 and asthma.